TipRanks
Daewoong Pharmaceutical Co., Ltd. (KR:069620)
:069620
South Korea Market
069620
Daewoong Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports

Daewoong Pharmaceutical Co., Ltd. (069620) Income Statement

― Followers

Daewoong Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q2 2026), Daewoong Pharmaceutical Co., Ltd.'s total revenue was ₩448.46B, an increase of 10.61% from the same quarter last year. In Q2, Daewoong Pharmaceutical Co., Ltd.'s net income was ₩33.37B. See Daewoong Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₩ 1.57T₩ 1.42T₩ 1.38T₩ 1.28T₩ 1.15T
Gross Profit
₩ 812.85B₩ 734.17B₩ 687.11B₩ 638.96B₩ 544.75B
Operating Expenses
₩ 617.34B₩ 586.23B₩ 565.57B₩ 543.16B₩ 455.84B
Depreciation and Amortization
₩ 50.27B₩ 48.98B₩ 43.80B₩ 39.69B₩ 40.88B
EBITDA
₩ 245.78B₩ 112.52B₩ 164.91B₩ 86.80B₩ 129.61B
Operating Income
₩ 195.51B₩ 147.94B₩ 121.12B₩ 95.80B₩ 88.73B
Other Income/Expenses
₩ -3.67B₩ -91.39B₩ 881.52M₩ -57.47B₩ -68.97B
Pretax Income
₩ 191.83B₩ 56.55B₩ 122.00B₩ 38.33B₩ 19.76B
Net Income
₩ 195.86B₩ 24.73B₩ 121.74B₩ 42.24B₩ 24.51B
Per Share Metrics
Basic EPS
₩ 17.02K₩ 2.15K₩ 10.66K₩ 3.82K₩ 2.23K
Diluted EPS
₩ 17.02K₩ 2.15K₩ 10.66K₩ 3.82K₩ 2.23K
Weighted Average Shares Outstanding
 11.59M 11.51M 11.42M 11.07M 11.01M
Weighted Average Shares Outstanding (Diluted)
 11.59M 11.51M 11.42M 11.07M 11.01M
Currency in KRW

Daewoong Pharmaceutical Co., Ltd. Earnings and Revenue History